MEGAN SLATER: Open Payments
NPI 1659035822 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 39 payments from 12 companies in 2025. Trend: 2023 $878 · 2024 $1,239 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $290 |
| ViiV Healthcare Company | 8 | $152 |
| Novo Nordisk Inc | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| ABBVIE INC. | 3 | $60 |
| Theratechnologies Inc. | 2 | $53 |
| Verity Pharmaceuticals Inc. | 2 | $45 |
| Napo Pharmaceuticals Inc | 2 | $41 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
Products named: DOVATO, AIRSUPRA, EGRIFTA, Tlando, Rybelsus, Mytesi, VRAYLAR, The Cologuard Plus Collection Kit.
Industry payments across GA — which companies pay providers there.
